Purpose: To describe our managing strategy for COVID-19 emergency, to evaluate the adherence to intravitreal treatment (AtT) rate during the outbreak in a referral hospital in Milan and to correlate it with patients clinical features. Methods: AtT rate of patients with scheduled intravitreal injections (IVT) during the COVID-19 outbreak from 23/02/20 to 31/03/20 was compared to the previous trimester and with March 2019. The impact of age, sex, visual function and diagnosis on the AtT rate during unlocked/locked weeks (from March 8) was evaluated. Results: Of 650 consecutive patients with scheduled IVT, AtT rate during the COVID-19 outbreak was 0.37. This was significantly lower compared to AtT registered in the previous trimester (0.92) and in the same weeks in 2019 (0.90) (both p <0.001). Patients adherent to treatment were significantly younger (p<0.001) and had a lower best-corrected visual acuity in the fellow eye (p=0.046). During the lockdown weeks AtT rate was significantly lower than in the two unlocked weeks (0.19 vs 0.73, p<0.001). In addition, the AtT rate in patients classified as "Emergent" during the lockdown weeks was 0.60. Conclusions: These preliminary results can help the retina specialist community to foresee this unique scenario and to develop successful management strategies.
The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases: report from a referral hospital in Milan / F. Viola, P. Milella, F.P. Giuffrida, S. Ganci, A. Invernizzi. - In: RETINA. - ISSN 0275-004X. - 41:4(2021 Apr), pp. 701-705. [10.1097/IAE.0000000000002941]
The impact of coronavirus disease (COVID-19) pandemic on intravitreal injections treatment for macular diseases: report from a referral hospital in Milan
F. Viola
Primo
;P. MilellaSecondo
;F.P. Giuffrida;A. InvernizziUltimo
2021
Abstract
Purpose: To describe our managing strategy for COVID-19 emergency, to evaluate the adherence to intravitreal treatment (AtT) rate during the outbreak in a referral hospital in Milan and to correlate it with patients clinical features. Methods: AtT rate of patients with scheduled intravitreal injections (IVT) during the COVID-19 outbreak from 23/02/20 to 31/03/20 was compared to the previous trimester and with March 2019. The impact of age, sex, visual function and diagnosis on the AtT rate during unlocked/locked weeks (from March 8) was evaluated. Results: Of 650 consecutive patients with scheduled IVT, AtT rate during the COVID-19 outbreak was 0.37. This was significantly lower compared to AtT registered in the previous trimester (0.92) and in the same weeks in 2019 (0.90) (both p <0.001). Patients adherent to treatment were significantly younger (p<0.001) and had a lower best-corrected visual acuity in the fellow eye (p=0.046). During the lockdown weeks AtT rate was significantly lower than in the two unlocked weeks (0.19 vs 0.73, p<0.001). In addition, the AtT rate in patients classified as "Emergent" during the lockdown weeks was 0.60. Conclusions: These preliminary results can help the retina specialist community to foresee this unique scenario and to develop successful management strategies.File | Dimensione | Formato | |
---|---|---|---|
2020 - Retina - Covid impact.pdf
Open Access dal 08/08/2021
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri |
IMPACT OF CORONAVIRUS DISEASE PANDEMIC ON INTRAVITREAL INJECTIONS TREATMENT FOR MACULAR DISEASES_Report From a Referral Hospital in Milan.pdf
solo utenti autorizzati
Tipologia:
Publisher's version/PDF
Dimensione
156.67 kB
Formato
Adobe PDF
|
156.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.